FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称SUNVOZERTINIB
异名/同义词2-PROPENAMIDE, N-(5-((4-((5-CHLORO-4-FLUORO-2-(1-HYDROXY-1- METHYLETHYL)PHENYL)AMINO)-2-PYRIMIDINYL)AMINO)-2-((3R)-3-(DIMETHYLAMINO)-1-PYRROLIDINYL)-4-METHOXYPHENYL)-
A1801
A-1801
ASYM-122507
DZ00000586
DZ0586
DZ-0586
DZD9008
DZD-9008
N-(5-((4-((5-CHLORO-4-FLUORO-2-(1-HYDROXY-1-METHYLETHYL)PHENYL)AMINO)PYRIMIDIN-2-YL)AMINO)-2-((3R)-3-(DIMETHYLAMINO)PYRROLIDIN-1-YL)-4-METHOXYPHENYL)PROP-2-ENAMIDE
SUNVOZERTINIB
SUNVOZERTINIB [INN]
SUNVOZERTINIB [USAN]
SUNVOZERTINIB [WHO-DD]
CAS登记号2370013-12-8
物质唯一标识(Unique Ingredient Identifier)L1Q2K5JYO8
分子式C29H35ClFN7O3
国际化合物标识(International Chemical Identifier,InChI)BTMKEDDEMKKSEF-QGZVFWFLSA-N
SMILESc1(cc(c(cc1NC(C=C)=O)Nc2nc(ccn2)Nc3c(cc(c(c3)Cl)F)C(C)(O)C)OC)N4C[C@@H](CC4)N(C)C
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System